New practice parameters published for both atopic dermatitis and anaphylaxis
|
|
Newly revised practice parameters on both atopic dermatitis and anaphylaxis were published online today in the Annals of Allergy, Asthma & Immunology. These clinical guidelines are a product of the Joint Task Force on Practice Parameters (JTFPP), a partnership between the American College of Allergy, Asthma, and Immunology (ACAAI) and the American Academy of Allergy, Asthma & Immunology (AAAAI).
The JTFPP works to develop both traditional practice parameters and GRADE (Grading of Recommendations Assessment, Development and Evaluation) guidelines which clearly describe evidence certainty and strength of recommendations, informed by clinical experts and patient partners.
The College thanks and applauds its many members who led and contributed to the authorship of these guidelines, including JTFPP Co-Chairs Jay Lieberman, MD, FACAAI, and Marcus Shaker, MD, FACAAI.
Anaphylaxis: A 2023 practice parameter update
According to lead author David B.K. Golden, MDCM, “With important new guidance related to diagnostic evaluation, anaphylaxis in infants and in community settings, epinephrine treatment, mast cell conditions, beta-blockers and ACE inhibitors, and peri-operative anaphylaxis, these guidelines translate recent advances in the understanding of severe allergic reactions to help all healthcare professionals provide individualized care to each patient at the right time, in the right place, every time.”
An accompanying editorial highlights major changes reflected in the new anaphylaxis practice parameter.
Atopic Dermatitis (Eczema) Guidelines: 2023 AAAAI/ACAAI Joint Task Force (JTF) on Practice Parameters GRADE - and Institute of Medicine-based recommendations
“The 2023 JTFPP atopic dermatitis guideline represents an advancement in trustworthy allergy guidelines,” said lead author Derek Chu, M.D., Ph.D. “It is distinguished from other guidelines through systematic reviews of the evidence with multidisciplinary panelist engagement, adherence to GRADE – a rigorous guideline development process, as well as the involvement of the patient and caregiver voice from start to finish.”
In addition to these guidelines, the JTFPP is actively developing clinical guidelines on inborn errors of immunity, allergen immunotherapy, severe asthma, chronic urticaria, vaccine allergy, and food allergy, with recent guidelines available on drug allergy, chronic sinusitis, allergy diagnostics, eosinophilic esophagitis, allergic rhinitis, and stinging insect allergy. Find them at allergyparameters.org
|
|
|
|
